Certified by Founder
Lodge
CatalYm GmbH
start up
Germany
- Martinsried, Bayern
- 16/07/2024
- Series D
- $150,000,000
Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.
- Industry Biotechnology Research
- Website https://www.catalym.com/
- LinkedIn https://www.linkedin.com/company/catalym/
Related People
Phil L'HuillierFounder
United Kingdom -
Greater London, England
Specialties: CEO, Leadership, Corporate Development & strategy, Clinical Development, Business Development in biotechnology and pharmaceutical sectors
Potpie AI | $2,200,000 | (Feb 24, 2026)
Solid (AI for Data) | $20,000,000 | (Feb 24, 2026)
Comeryx | $7,500,000 | (Feb 24, 2026)
Maazah | $2,000,000 | (Feb 24, 2026)
Turgo.ai | $1,000,000 | (Feb 24, 2026)
Sherpas | $3,200,000 | (Feb 24, 2026)
Patientdesk.ai (YC W26) | $1,000,000 | (Feb 24, 2026)
Aalyria | $100,000,000 | (Feb 24, 2026)
Ubicquia, Inc | $106,000,000 | (Feb 24, 2026)
Freeform | $67,000,000 | (Feb 24, 2026)
Coral Care | $13,000,000 | (Feb 24, 2026)
Reload | $2,275,000 | (Feb 24, 2026)